cervical%20cancer%20-%20prevention%20-and-%20screening
CERVICAL CANCER - PREVENTION & SCREENING
Mortality due to cervical cancer can be reduced by prevention, early detection & treatment.
Vaccination may be started as early as 9 years old.
Vaccination may reduce the incidence of HPV-related disease.
Screening for cervical cancer after vaccination is still recommended because only 70% of the virus types associated w/ invasive cervical cancer consist of HPV 16 & 18 types & women may not be entirely protected if they have been infected w/ other HPV types prior to vaccination.

Introduction

Routine Vaccination

  • Females, 11-12 years of age, are recommended to receive 2 doses of human papilloma virus (HPV) vaccine 6-12 months apart
    • Vaccination may be started as early as 9 years old
  • World Health Organization (WHO) recommends a 2-dose vaccination schedule with a minimum interval of 6 months between doses for females <15 years old
    • For females ≥15 years old and immunocompromised individuals, the 3-dose vaccination schedule is recommended

Catch-Up Dose

  • Females, 13-26 years of age, who have not been previously vaccinated or those who have not completed the doses
    • Those who have not received any previous HPV vaccination should receive a 3-dose vaccine series  
    • Those who have received 2 doses of HPV vaccine at least 5 months apart before the age of 15 years are adequately vaccinated and do not need any additional HPV vaccine dose
    • Those who have received only 1 dose or 2 doses <5 months apart before the age of 15 years are not adequately vaccinated and must receive an additional HPV vaccine dose 
  • HPV exposure risks should be discussed with females 18-45 years old
    • Vaccination would provide full benefit to sexually active females who have not been infected by HPV
    • Less benefit is provided to sexually active females who have been infected by one or more HPV types
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
14 Oct 2017
In pregnant women, adherence to recommended dietary intake of fat and fibre is associated with a more beneficial and richer gut microbiota which, in turn, decreases levels of the inflammation marker glycoprotein acetylation (GlycA), a study has shown.
16 Oct 2017
Elagolix is safe and effective for reducing heavy menstrual bleeding in females with fibroids, a new dose-ranging, multiple-cohort study has shown.
13 Oct 2017
Dr Joon Kiong Lee discusses pharmacotherapy for osteoporosis and the role of FLS in fracture prevention
Tristan Manalac, 06 Oct 2017
In women with polycystic ovary syndrome (PCOS), combined oral contraceptive (COC) with spironolactone is more effective than metformin in reducing symptoms while showing a similar safety profile, according to a new randomized clinical trial (RCT).